I went from 18st to 8.5st on Mounjaro, there's a dark side coming off no-one talks about – I've gone back on it 3 times
Plus, the financial worries that come with being on the jab
JAB SNAG I went from 18st to 8.5st on Mounjaro, there's a dark side coming off no-one talks about – I've gone back on it 3 times
A WOMAN has shared how she lost a staggering 9.5 stone being on Mounjaro, but said there was a dark side that no one talks about when you come off.
Shannon revealed she went from 18 stone to 8.5 stone on the popular weight loss jab, and she's been on it three times after 'failing' to ditch it.
Advertisement
4
Shannon went from 18 stone to 8.5 stone on weight loss jab Mounjaro
Credit: TikTok/@shanmacxo
4
She now feels more confident, but claims the jab is 'addictive'
Credit: TikTok/@shanmacxo
On her @shanmacxo account, she insisted that it was 'genuinely the best thing I ever did for myself' and said 'it will change your life.'
However, coming off the injections is extremely tough - and she claims she is now an 'addict' of its effects.
In a video that has 85,000 views, she shared: 'I've been taking Mounjaro now for 16 months. I have gone from 18 stone, and I weigh 8 stone 5 now."
She shared how she had come off the weight loss jab three times 'cold turkey' and each time has 'completely failed and got back on it.'
Advertisement
Shannon said she'd been on a maintenance dose of 7.5 and had been injecting herself every week or every other week.
But when it came to stopping, she faced a big obstacle.
Shannon explained: 'The last week or so has been like I have been an addict. My brain has been like, I need it, I need to order it.
'I'm eating far too much. I've got this severe, sickening worry that I'm gonna put weight on, checking the scales all of the time.'
Advertisement
Shannon said she thinks her issues come from her feeling like she was 'big' her whole life.
She said that she's been really worried about putting on a single pound and caved about bought more of the weight loss jab, although the decision left her "disappointed in myself."
I was depressed and exhausted before Mounjaro - I've lost 4 stone but have had FOUL side effects, including eggy burps
RELIANT FOR LIFE?
And it's not just her who finds the weight loss method 'addictive.'
She explained: 'And friends do the same as well, where they've come off it, lost so much weight, and then they're just like, 'I need— I need it back.''
Advertisement
Due to her reliance on the controversial weight loss jab, she wondered if she will now be reliant on it 'for life'.
She continued: 'Is it a life thing? It's not sustainable financially for life.
'I feel like this isn't talked about enough, and how we are supposed to manage the weight loss after— and the food noise—it's a real struggle."
4
More and more people buying Mounjaro through online pharmacies, without sufficient checks
Credit: Alamy
Advertisement
JAB WARNING
Mounjaro (tirzepatide) - which can have negative side effects for some users - became available in the UK in February 2024, primarily for private use.
But access to the weight loss jab through the NHS has gradually been rolled out.
Is it a life thing? It's not sustainable financially for life
Shannon
By activating GIP and GLP-1 receptors, Mounjaro slows down the emptying of the stomach, making you feel fuller for longer and reducing appetite.
This can lead to eating less food overall.
Advertisement
In addition to nasty side effects, those debating whether to begin using Mounjaro should know that it can also have fatal consequences.
Everything you need to know about fat jabs
Weight loss jabs are all the rage as studies and patient stories reveal they help people shed flab at almost unbelievable rates, as well as appearing to reduce the risk of serious diseases.
Wegovy – a modified version of type 2 diabetes drug Ozempic – and Mounjaro are the leading weight loss injections used in the UK.
Wegovy, real name semaglutide, has been used on the NHS for years while Mounjaro (tirzepatide) is a newer and more powerful addition to the market.
Mounjaro accounts for most private prescriptions for weight loss and is set to join Wegovy as an NHS staple this year.
How do they work?
The jabs work by suppressing your appetite, making you eat less so your body burns fat for energy instead and you lose weight.
They do this my mimicking a hormone called GLP-1, which signals to the brain when the stomach is full, so the drugs are officially called GLP-1 receptor agonists.
They slow down digestion and increase insulin production, lowering blood sugar, which is why they were first developed to treat type 2 diabetes in which patients' sugar levels are too high.
Can I get them?
NHS prescriptions of weight loss drugs, mainly Wegovy and an older version called Saxenda (chemical name liraglutide), are controlled through specialist weight loss clinics.
Typically a patient will have to have a body mass index (BMI) of 30 or higher, classifying them as medically obese, and also have a weight-related health condition such as high blood pressure.
GPs generally do not prescribe the drugs for weight loss.
Private prescribers offer the jabs, most commonly Mounjaro, to anyone who is obese (BMI of 30+) or overweight (BMI 25-30) with a weight-related health risk.
Private pharmacies have been rapped for handing them out too easily and video calls or face-to-face appointments are now mandatory to check a patient is being truthful about their size and health.
Are there any risks?
Yes – side effects are common but most are relatively mild.
Around half of people taking the drug experience gut issues, including sickness, bloating, acid reflux, constipation and diarrhoea.
Dr Sarah Jarvis, GP and clinical consultant at patient.info, said: 'One of the more uncommon side effects is severe acute pancreatitis, which is extremely painful and happens to one in 500 people.'
Other uncommon side effects include altered taste, kidney problems, allergic reactions, gallbladder problems and hypoglycemia.
Evidence has so far been inconclusive about whether the injections are damaging to patients' mental health.
Figures obtained by The Sun show that, up to January 2025, 85 patient deaths in the UK were suspected to be linked to the medicines.
The injections are licensed for patients with type 2 diabetes and are administered every seven days.
They are also available to assist those who are clinically obese (with a Body Mass Index of 30 or over).
Advertisement
The drugs, which have been widely regarded as 'fat jabs', can be prescribed by a practitioner - such as a doctor, nurse or a pharmacist-independent prescriber.
But increasingly, we are seeing more and more people buying them through online pharmacies, without sufficient checks.
Not only this, but recently, figures from the Medicines and Healthcare products Regulatory Agency revealed that fat jabs had been linked to 82 deaths across the UK.
4
Mounjaro slows down the emptying of the stomach, making you feel fuller for longer
Credit: Alamy
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
South Wales Argus
43 minutes ago
- South Wales Argus
Women's Prize for Fiction ‘greatest honour' as an intersex woman, says winner
Dutch author Yael van der Wouden won the accolade for her debut novel, The Safekeep, and used her winner's speech to champion the trans community, who have 'changed the system' and 'fought for health care'. The book, which explores repressed desire and the unresolved aftermath of the Holocaust in post-Second World War Netherlands, was described as an 'astonishing debut' by the head of the judges. The ceremony, held in central London on Thursday, saw the non-fiction prize awarded to physician Dr Rachel Clarke for The Story Of A Heart, which explores the human experience behind organ donation. In her winner's speech, after thanking the judges, van der Wouden said: 'I was a girl until I turned 13, and then, as I hit puberty, all that was supposed to happen did not quite happen. 'And if it did happen, it happened too much, and all at once my girlhood became an uncertain fact. 'I won't thrill you too much with the specifics, but the long and the short of it is that, hormonally, I'm intersex. 'This little fact defined my life throughout my teens, until I advocated for the health care that I needed. 'The surgery and the hormones that I needed, which not all intersex people need. Not all intersex people feel at odds with their gender presentation. 'I mention the fact that I did, because in the few precious moments here on stage, I am receiving, truly, the greatest honour of my life as a woman, presenting to you as a woman, and accepting this Women's Prize. Aria Aber, Miranda July, Nussaibah Younis, Elizabeth Strout, Sanam Mahloudji and Yael van der Wouden at the ceremony (Ian West Media Assignments/PA) 'And that is because of every single trans person who's fought for health care, who changed the system, the law, societal standards, themselves. I stand on their shoulders.' The NHS website says intersex, or differences in sex development (DSD), is a group of rare conditions involving genes, hormones and reproductive organs that mean a person's sex development is different to most. In contrast, people who are transgender identify as a gender separate to the sex they were born in and sometimes go through gender-affirming surgery. Van der Wouden's novel follows Isabel, a young woman whose life in solitude is upended when her brother's girlfriend Eva comes to live in their family house in what turns into a summer of obsession, suspicion and desire. The chairwoman of the judges for the fiction prize, writer Kit de Waal, said: 'This astonishing debut is a classic in the making, a story to be loved and appreciated for generations to come. Books like this don't come along every day.' Van der Wouden will receive £30,000 and a limited-edition bronze statuette known as the Bessie, which was created and donated by artist Grizel Niven. Rachel Clarke won the non-fiction prize (Ian West Media Assignments/PA) The judging panel for the Women's Prize for Fiction included novelist and journalist Diana Evans, author and journalist Bryony Gordon, writer and magazine editor Deborah Joseph, and musician and composer Amelia Warner. Clarke said she has 'literally been a feminist since I was too young to know what that word even meant', as she collected her award. The physician's book recounts two family stories, documenting how medical staff take care of nine-year-old Kiera in her final hours after a car accident, while offering a new life to nine-year-old Max who is suffering from heart failure from a viral infection. Clarke, who is behind the books Breathtaking and Your Life In My Hands: A Junior Doctor's Story, will receive £30,000 and a limited-edition piece of art known as the Charlotte, both gifted by the Charlotte Aitken Trust. The judging panel for the non-fiction prize included writer and broadcaster Dr Leah Broad, whose work focuses on women's cultural history, and novelist and critic Elizabeth Buchan. Previous winners of the fiction prize include Tayari Jones for An American Marriage and Madeline Miller for The Song Of Achilles, while the first non-fiction prize was awarded last year to Naomi Klein for Doppelganger: A Trip Into The Mirror World. The awards were announced by the Women's Prize Trust, a UK charity that aims to 'create equitable opportunities for women in the world of books and beyond'.
Glasgow Times
an hour ago
- Glasgow Times
Women's Prize for Fiction ‘greatest honour' as an intersex woman, says winner
Dutch author Yael van der Wouden won the accolade for her debut novel, The Safekeep, and used her winner's speech to champion the trans community, who have 'changed the system' and 'fought for health care'. The book, which explores repressed desire and the unresolved aftermath of the Holocaust in post-Second World War Netherlands, was described as an 'astonishing debut' by the head of the judges. The ceremony, held in central London on Thursday, saw the non-fiction prize awarded to physician Dr Rachel Clarke for The Story Of A Heart, which explores the human experience behind organ donation. In her winner's speech, after thanking the judges, van der Wouden said: 'I was a girl until I turned 13, and then, as I hit puberty, all that was supposed to happen did not quite happen. 'And if it did happen, it happened too much, and all at once my girlhood became an uncertain fact. 'I won't thrill you too much with the specifics, but the long and the short of it is that, hormonally, I'm intersex. 'This little fact defined my life throughout my teens, until I advocated for the health care that I needed. 'The surgery and the hormones that I needed, which not all intersex people need. Not all intersex people feel at odds with their gender presentation. 'I mention the fact that I did, because in the few precious moments here on stage, I am receiving, truly, the greatest honour of my life as a woman, presenting to you as a woman, and accepting this Women's Prize. Aria Aber, Miranda July, Nussaibah Younis, Elizabeth Strout, Sanam Mahloudji and Yael van der Wouden at the ceremony (Ian West Media Assignments/PA) 'And that is because of every single trans person who's fought for health care, who changed the system, the law, societal standards, themselves. I stand on their shoulders.' The NHS website says intersex, or differences in sex development (DSD), is a group of rare conditions involving genes, hormones and reproductive organs that mean a person's sex development is different to most. In contrast, people who are transgender identify as a gender separate to the sex they were born in and sometimes go through gender-affirming surgery. Van der Wouden's novel follows Isabel, a young woman whose life in solitude is upended when her brother's girlfriend Eva comes to live in their family house in what turns into a summer of obsession, suspicion and desire. The chairwoman of the judges for the fiction prize, writer Kit de Waal, said: 'This astonishing debut is a classic in the making, a story to be loved and appreciated for generations to come. Books like this don't come along every day.' Van der Wouden will receive £30,000 and a limited-edition bronze statuette known as the Bessie, which was created and donated by artist Grizel Niven. Rachel Clarke won the non-fiction prize (Ian West Media Assignments/PA) The judging panel for the Women's Prize for Fiction included novelist and journalist Diana Evans, author and journalist Bryony Gordon, writer and magazine editor Deborah Joseph, and musician and composer Amelia Warner. Clarke said she has 'literally been a feminist since I was too young to know what that word even meant', as she collected her award. The physician's book recounts two family stories, documenting how medical staff take care of nine-year-old Kiera in her final hours after a car accident, while offering a new life to nine-year-old Max who is suffering from heart failure from a viral infection. Clarke, who is behind the books Breathtaking and Your Life In My Hands: A Junior Doctor's Story, will receive £30,000 and a limited-edition piece of art known as the Charlotte, both gifted by the Charlotte Aitken Trust. The judging panel for the non-fiction prize included writer and broadcaster Dr Leah Broad, whose work focuses on women's cultural history, and novelist and critic Elizabeth Buchan. Previous winners of the fiction prize include Tayari Jones for An American Marriage and Madeline Miller for The Song Of Achilles, while the first non-fiction prize was awarded last year to Naomi Klein for Doppelganger: A Trip Into The Mirror World. The awards were announced by the Women's Prize Trust, a UK charity that aims to 'create equitable opportunities for women in the world of books and beyond'.
Telegraph
an hour ago
- Telegraph
Weight-loss drugs could become as common as statins, says England's top doctor
Weight-loss jabs could eventually be doled out like statins, England's top doctor has said. Prof Sir Stephen Powis, medical director of the NHS, said the health service should consider the mass rollout of medication to 'turn the tide' on Britain's obesity crisis. The NHS has been criticised for tightly rationing the jabs, having drawn up a plan for a 12-year rollout. GPs in England will start prescribing the injections from this month, but only to those with severe obesity and at least one weight-related health problem. Until now, jabs have only been available via specialist services with long waiting lists. However, NHS pilot schemes will look at ways to roll them out far more widely, including offering jabs through the post, from online pharmacies. Statins are one of the most commonly prescribed drugs in the UK, with about eight million people taking them to cut their chance of a heart attack and stroke. An estimated 1.5 million people are taking weight-loss jabs in the UK, with the vast majority paying for them privately, at around £200 a month. 'Exciting milestone' Speaking at the NHS ConfedExpo conference in Manchester, Sir Stephen hailed the rollout in GP surgeries as an 'exciting milestone' and said NHS officials are also examining ways to ' broaden access to the drugs '. Around 29 per cent of adults in the UK are obese. Sir Stephen said: 'Right now, obesity is estimated to cost the NHS approximately £11.4 billion every year – this financial burden is unsustainable for the NHS and wider economy. 'We have to turn the tide. We have to and will go further, and faster. 'In just a few years from now, some of today's weight-loss drugs will be available at much lower cost. This could completely transform access to these innovative treatments. 'But we will and must be guided by the evidence base and must do this safely and sustainably, in a way that ensures that we are equipped as a health service to deal with the demand.' 'We'll learn how to deploy them better' Sir Stephen said that the 'exciting new class of medication' would see wider rollout in the same way that statins had been rolled out en masse. 'There will be more drugs coming on the market. There will be different prices for drugs. We will get to generics, which means that prices will fall,' he said. 'We have been through this over statins, and the use of statins is now very different from when they first came out, and I've no doubt that will be the same for these drugs. So it's very exciting.' The senior doctor said research suggesting they can prevent and treat multiple diseases, including heart and kidney disease, also meant they were like statins. 'It's highly likely that they will become more widespread, the evidence base will increase. We will learn better how to deploy them,' he said.
